Effect of Trendelenburg Position on Patient State Index

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-65
SponsorSakarya University

About this trial

The goal of this observational study is to evaluate whether the Trendelenburg position affects electroencephalography-based depth of anesthesia monitoring and cerebral oxygenation during general anesthesia.

The main questions it aims to answer are:

* Does the Trendelenburg position cause a change in the Patient State Index (PSI), an Electroensephalography (EEG)-derived indicator of anesthetic depth? * Are changes in PSI associated with changes in frontal cerebral oxygen saturation (rSO₂) and hemodynamic parameters?

The study will include adult female patients undergoing elective laparoscopic gynecologic surgery under general anesthesia.

Participants will receive standard anesthesia and routine intraoperative monitoring. In addition to standard monitoring, Patient State Index (PSI) and frontal cerebral oxygen saturation (rSO₂) will be recorded using non-invasive sensors. No additional intervention will be performed for research purposes.

Physiological parameters including PSI, cerebral oxygen saturation, mean arterial pressure, heart rate, oxygen saturation, and end-tidal carbon dioxide will be recorded at predefined intraoperative time points before and after the Trendelenburg position.

The study aims to determine whether position-related physiological changes influence EEG-based anesthesia depth indices and to improve the interpretation of intraoperative brain monitoring.

Eligibility criteria

Qualifiers

Female patients aged 18-65 years

American Society of Anesthesiologists (ASA) physical status I-III

Scheduled for elective laparoscopic hysterectomy under general anesthesia

Ability to provide written informed consent

Disqualifiers

History of neurological disease (e.g., stroke, epilepsy)

Known cerebrovascular disease, glaucoma, or retinal disease

Severe cardiac or pulmonary disease

Contraindication to near-infrared spectroscopy sensor placement

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

60 Participants
are grouped into 1 trial group

Sponsors and collaborators